Bio-Rad Launches Two Bio-Plex Pro™ Wash Stations

Date: 
06/30/2008

Wash Stations Designed and Optimized for xMAP Assays

HERCULES, CA — June 30, 2008 — Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today the launch of two Bio-Plex Pro™ wash stations for washing bead-based assays. The Bio-Plex Pro wash stations is used exclusively for magnetic beads. The Bio-Plex Pro II wash stations automates magnetic and vacuum wash steps for researchers who use a combination of magnetic and polystyrene assays.

Magnetic assays available for the Bio-Plex Pro and Pro II wash stations include human precision cytokines, human isotyping, human diabetes, human angiogenesis and human acute phase.

"Both wash stations are automated, plug-and-play instruments, designed with a simplified protocol in mind," said Emily C. Dale, Bio-Rad's Bio-Plex marketing manager. "Users can expect consistent results regardless of the wash station operator."

Both wash stations were designed and optimized for xMAP assays and have a preset program for the Bio-Plex assay protocols. The units can be programmed by the user for custom wash volumes and other parameters may also be programmed to meet other assay needs.

Unlike manual washing methods, which involve as many as 14 separate steps, the Bio-Plex Pro wash stations simply require placing the assay plate on the station, selecting the wash program and pressing "start." Results are available in three to four minutes.

For further information on the Bio-Plex Pro wash stations and the Bio-Plex Pro II wash stations, please visit www.bio-rad.com/bio-plex/.

About Bio-Rad
Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs approximately 6,300 people globally and had revenues approaching $1.5 billion in 2007. For more information, visit www.bio-rad.com.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, "believe," "expect," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the "Risk Factors" in the Company's public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, as updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc. disclaims any obligation to update these forward-looking statements.